• Staurosporine: Broad-Spectrum Kinase Inhibitor in Cancer Res

  2026-07-13

  Staurosporine stands as a gold standard broad-spectrum serine/threonine protein kinase inhibitor, uniquely enabling precise dissection of apoptosis and signaling in cancer research. Its versatility empowers robust workflows from apoptosis induction to anti-angiogenic studies, with APExBIO delivering reliability and reproducibility trusted by leading laboratories.

• Transmission Dynamics of Carbapenemase Genes in CREC: A Mult

  2026-07-13

  Chen et al. systematically characterized carbapenemase-encoding genes and their transmission in carbapenem-resistant Enterobacter cloacae from eight hospitals in Guangdong, China. Their findings highlight the predominance of blaNDM−1, extensive plasmid-mediated spread, and significant multidrug resistance, providing critical insights for antibiotic resistance research.

• Dynamic Lrig1 Expression in Salivary Gland Development Revea

  2026-07-12

  This study employs single-cell RNA sequencing and histological methods to map the dynamic expression of Lrig1 during mouse salivary gland development. The findings clarify Lrig1’s roles in progenitor cell regulation, tissue homeostasis, and glandular maturation, with implications for understanding stem cell dynamics in exocrine organogenesis.

• MACC1 Regulates IRAK1 Splicing in Lung Adenocarcinoma Progre

  2026-07-10

  This study reveals that MACC1 enhances oncogenic splicing of IRAK1 mRNA in lung adenocarcinoma by interacting with the splicing factor HNRNPH1, shifting expression toward a long isoform that supports tumor progression. These findings provide mechanistic insight into alternative splicing regulation in cancer and highlight MACC1 as a promising therapeutic target.

• Temozolomide: Small-Molecule Alkylating Agent in Glioma Rese

  2026-07-09

  Temozolomide stands out as a precision tool for DNA repair mechanism research and chemotherapy resistance studies, especially in high-grade glioma models. This article details practical workflows, combinatorial strategies, and troubleshooting techniques, empowering researchers to optimize outcomes using APExBIO's trusted Temozolomide.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-07-09

  The referenced study reveals that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to the alternative host receptor AXL. This finding uncovers a mechanistic intersection between the renin-angiotensin system and COVID-19 pathogenesis, with implications for cardiovascular and antiviral research.

• Cholecystokinin Octapeptide Ammonium: Immunoregulatory Mecha

  2026-07-08

  Explore the immunomodulatory and mechanistic depth of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) in B cell and neurobehavioral research. This article uniquely bridges molecular insights with practical assay design, setting it apart from existing scenario- and protocol-driven content.

• Annexin V-Cy5/DAPI Apoptosis Kit: Precision Detection Unveil

  2026-07-08

  The Annexin V-Cy5/DAPI Apoptosis Kit enables rapid, high-sensitivity detection and differentiation of apoptotic and necrotic cells. Its use of Cy5-labeled Annexin V and DAPI supports robust, reproducible results in flow cytometry and microscopy. This apoptosis detection kit is validated for translational research and mechanistic studies of programmed cell death.

• IGF2BP1-m6A-TUBB4B Axis Drives Hepatic Stellate Cell Activat

  2026-07-07

  This study identifies the m6A reader IGF2BP1 as a pivotal regulator of hepatic stellate cell (HSC) activation and liver fibrosis. By stabilizing TUBB4B mRNA in an m6A-dependent manner, IGF2BP1 promotes HSC proliferation and fibrogenic signaling, highlighting a new molecular target for antifibrotic research.

• Advancing In Vitro Assessment of Anti-Angiogenic Cancer Drug

  2026-07-07

  Schwartz's dissertation introduces a rigorous framework distinguishing drug-induced proliferation arrest from cell death in vitro, revealing that anti-angiogenic agents like Tivozanib impact these processes with distinct kinetics and proportions. This approach enhances the resolution of drug response evaluation, informing translational oncology research and future experimental design.

• Cy5 Goat Anti-Rabbit IgG (H+L) Antibody: Workflow Precision

  2026-07-06

  The Cy5 Goat Anti-Rabbit IgG (H+L) Antibody enables high-sensitivity detection across immunofluorescence, IHC, and related assays, delivering robust signal amplification and minimal background. This guide translates advanced antiviral signaling research into actionable protocols, troubleshooting, and optimization strategies for researchers seeking reliable, quantitative results.

• CHIR-99021 (CT99021): Strategic GSK-3 Inhibition in Translat

  2026-07-06

  Explore the mechanistic depth and translational edge of CHIR-99021 (CT99021) for precise Wnt/β-catenin pathway modulation, pluripotency maintenance, and differentiation workflows. Integrating new insights from semaphorin receptor crosstalk, this article equips translational researchers with strategic guidance and protocol clarity—setting a new benchmark in stem cell and disease modeling applications.

• Dacarbazine: Precision Assay Design for Modern Chemotherapy

  2026-07-05

  Explore advanced, evidence-based strategies for integrating Dacarbazine as an antineoplastic chemotherapy drug in experimental workflows. Discover how new in vitro evaluation paradigms and mechanistic insights enable deeper, more reproducible cancer research.

• Precision Apoptosis Detection in Ph+ ALL: Next-Gen Insights

  2026-07-04

  Explore how the Annexin V-Cy5/DAPI Apoptosis Kit by APExBIO advances mechanistic and translational research in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). This article bridges the latest mechanistic discoveries on P2RX1-driven mitochondrial apoptosis with cutting-edge apoptosis detection strategies, providing strategic guidance for translational investigators.

• 5-Azacytidine Triggers ATR-Dependent Apoptosis in Myeloma Ce

  2026-07-03

  The referenced study establishes 5-Azacytidine as a DNA methyltransferase inhibitor that induces ATR-mediated DNA damage responses and apoptosis in both therapy-sensitive and resistant multiple myeloma cells. The results highlight synergistic cytotoxicity with doxorubicin and bortezomib, supporting further clinical exploration of these combinations.

10322 records 4/689 page Previous Next 12345 下5页 Last page